New York’s Cannabis Control Board (the CCB or the board) commenced their duties this fall, starting with their first board meeting on Tuesday, Oct. 5, and most recently on Nov. 3. In their first meeting, the board authorized dispensaries to sell flower marijuana products to qualified patients, but home cultivation for patients remained prohibited because officials failed to meet a deadline to develop corresponding regulations. The board appointed Jason Starr as chief equity officer. Starr previously served as an assistant counsel to former New York Gov. Andrew Cuomo and also worked in the New York Civil Liberties Union.

The CCB met for the second time on Oct. 21, producing two new resolutions: the board approved the executive director’s staffing recommendations for specific positions within the Office of Cannabis Management; and authorized the Office of Cannabis Management to file the proposed regulations for the home cultivation of medical cannabis for certified patient use.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]